Express News | Zhejiang Yatai Pharmaceutical: Reconfirmed as a high-tech enterprise.

BreakingsJan 3 16:40

Express News | Zhejiang Yatai Pharmaceutical: New specifications for injectable cefmetazole sodium have been approved.

BreakingsDec 13, 2024 16:25

Zhejiang Yatai Pharmaceutical (002370.SZ): Termination of the investment project for the funds raised from Convertible Bonds.

On December 11, Ge Long Hui reported that Zhejiang Yatai Pharmaceutical (002370.SZ) announced that at the 33rd meeting of the 7th Board of Directors and the 18th meeting of the 7th Supervisory Board held on December 11, 2024, it approved the "Proposal for Terminating the Fundraising Project for Convertible Bonds." 1. The Phase I and II projects of Zhejiang Yatai Pharmaceutical Modern Pharmaceutical Formulations consist of two independent lyophilized powder injection workshops, a penicillin workshop, a solid preparations workshop, a cephalosporin workshop (capsules and powder injections), a patch workshop, a raw and auxiliary materials finished product warehouse, a quality inspection workshop, a Sewerage treatment center, and dormitories.

Gelonghui FinanceDec 11, 2024 18:24

Zhejiang Yatai Pharmaceutical (002370.SZ): Pantoprazole Sodium for Injection passes consistency evaluation.

Zhejiang Yatai Pharmaceutical (002370.SZ) announced that the company recently received the approval and issuance from the National Medical Products Administration regarding...

Zhitong FinanceNov 29, 2024 15:53

Zhejiang Yatai Pharmaceutical's Diltiazem Hydrochloride Tablets Enter Consistency Evaluation Review Stage

MT NewswiresNov 29, 2024 14:25

Asia Pacific Pharmaceutical: Report for the third quarter of 2024

SZSIOct 31, 2024 00:00 · Announcements